1 | 68Ga-DOTA-TATE PET/MR and PET/CT imaging | [1] Dotatate Dotatate | - | - | - | [1] 238 238 |
2 | 68Ga-DOTATATE | [2] Dotatate Dotatate, Dotatate gallium Ga-68 | - | - | - | [3] 75 75, 84, 238 |
3 | Alfacalcidol | [1] Alfacalcidol Alfacalcidol | [1] D01518
D01518
| [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [8] 41 41, 46, 49, 50, 96, 107, 235, 238 |
4 | BGJ398 | - | - | - | - | [1] 238 238 |
5 | Burosumab | [1] Burosumab Burosumab | [1] D10913
D10913
| [1] FGF23 FGF23 💬 | [11] Breast cancer Breast cancer, Calcium signaling pathway, Gastric cancer, MAPK signaling pathway, Melanoma, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton 💬 | [1] 238 238 |
6 | Cinacalcet | [1] Cinacalcet Cinacalcet | [2] D03504
D03504
,
D03505
| [1] CASR CASR 💬 | [2] NOD-like receptor signaling pathway NOD-like receptor signaling pathway, Parathyroid hormone synthesis, secretion and action 💬 | [1] 238 238 |
7 | Combination Product: 68Ga-DOTATATE PET/CT | [2] Dotatate Dotatate, Dotatate gallium Ga-68 | - | - | - | [1] 238 238 |
8 | Crysvita (burosumab-twza) Treatment | [1] Burosumab Burosumab | [1] D10913
D10913
| [1] FGF23 FGF23 💬 | [11] Breast cancer Breast cancer, Calcium signaling pathway, Gastric cancer, MAPK signaling pathway, Melanoma, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton 💬 | [1] 238 238 |
9 | DOTA-TATE | [1] Dotatate Dotatate | - | - | - | [1] 238 238 |
10 | Dotatate | [1] Dotatate Dotatate | - | - | - | [4] 41 41, 75, 84, 238 |
11 | High cheese intake. | - | - | - | - | [1] 238 238 |
12 | High milk intake. | - | - | - | - | [1] 238 238 |
13 | Iron | [1] Iron Iron | - | - | - | [6] 18 18, 96, 97, 238, 254, 284 |
14 | KRN23 | - | - | - | - | [1] 238 238 |
15 | Norditropine simplex | - | - | - | - | [1] 238 238 |
16 | Osteoblast biology study | - | - | - | - | [1] 238 238 |
17 | Osteomalacia | - | - | - | - | [1] 238 238 |
18 | Paricalcitol | [1] Paricalcitol Paricalcitol | [1] D00930
D00930
| [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [4] 19 19, 66, 218, 238 |
19 | Phosphate | [1] Phosphate ion Phosphate ion | - | - | - | [33] 2 2, 3, 6, 11, 12, 13, 15, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 238, 256, 276, 283, 284, 285, 286, 299 |
20 | Phosphate tablets. | [1] Phosphate ion Phosphate ion | - | - | - | [1] 238 238 |
21 | Phosphate. | [1] Phosphate ion Phosphate ion | - | - | - | [1] 238 238 |
22 | Phosphorus | [1] Phosphorus Phosphorus | - | - | - | [2] 8 8, 238 |
23 | Sevelamer | [1] Sevelamer Sevelamer | [3] D01983
D01983
,
D06642
,
D08512
| - | - | [2] 235 235, 238 |
24 | Somatropin | [1] Somatotropin Somatotropin | [1] D02691
D02691
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [19] 2 2, 3, 19, 46, 65, 74, 75, 78, 96, 107, 113, 187, 193, 195, 238, 265, 274, 276, 299 |
25 | Z-521 | - | - | - | - | [1] 238 238 |